Clinical Trial Update: V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update reporting results for V221-019, a concomitant-use study with Pneumococcal Conjugate Vaccine sponsored by Merck Sharp & Dohme LLC; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella
• Varicella

Drugs mentioned

• Pneumococcal conjugate vaccine (pneumococcal conjugate vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Measles, Mumps | Phase 3 | Status: COMPLETED | Results posted: 2010-02-10